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1. Introduction 
In a previous paper [l] we described the ketogenic 
effect of high concentrations of fructose in isolated 
perfused rat livers. The enhanced formation of ketone 
bodies resulted from an increased formation of acetyl- 
S-CoA from pyruvate. We concluded that the drop in 
the intracellular concentration of ATE which followed 
the application of fructose had led to a shift from the 
phosphorylated inactive form [2, see also 31 of pyru- 
vate dehydrogenase (EC 1.2.4.1) to the dephosphoryl- 
ated active form, and that this shift had resulted in an 
enhanced rate of pyruvate oxidation. 
The present studies were undertaken in order to 
prove this hypothesis. According to the results ob- 
tained the intravenous injection of fructose leads to a 
significant increase in active pyruvate dehydrogenase 
within a few minutes without affecting total pyruvate 
dehydrogenase activity. 
2. Experimental 
Chow fed male Wistar rats of an inbred strain of 
the Zentralinstitut fur Versuchstierzucht, Hannover- 
Linden/Germany (weight 200-240 g) were used. The 
animals were anesthetized with pentobarbital(50 
mg/kg, i.p.) and received then fructose (1.8 mmole/kg, 
i.v.) (femoral vein) within 3 min. Control animals 
received the same volume (5 ml/kg) of salino. Ei& 
min after the beginning of the intravenous injection 
liver tissue was obtained by freeze-clamping [4] and 
pulverized carefully in a mortar under liquid nitrogen. 
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The powder was transferred into a polypropylene 
centrifuge tube precooled in liquid nitrogen. After 
weighing the powder was brought to -45” by immer- 
sion of the centrifuge tube into precooled methanol. 
To 1 g of tissue powder 3 parts (w/v) of -23” C cold 
glycerol buffer mixture (glycerol 8.22 M, triethanol- 
amine 40 mM, dithioerythritol2 mM, EDTA 1 mM) 
were added. The mixture was homogenized 3 times 
for 15 set with an Ultraturrax homogenizer. During 
the homogenization the tube was immersed into 
-45” cold methanol. 
Immediately after homogenization aliquots were 
taken for measurement of pyruvate dehydrogenase 
activity. Other aliquots were brought to 15 mM Mg’+ 
by adding MgCla , incubated for various time periods 
at 37” and then used for the determination of pyru- 
vate dehydrogenase activity. 
2.1. Determination of pyruvate dehydrogenase activity 
Pyruvate dehydrogenase activity was determined 
by coupling the reaction with the arylamine acetyl- 
transferase (EC 2.3.1.5) reaction as described similarly 
by Schweet and Cheslock [5] . 
The assay mixture contained (final concentration 
given): potassium phosphate 50 mM pH 4.0, MgClz 
0.5 mM, NAD’ 1.5 mM, nicotinamide 15 mM, CoA- 
SH 0.125 mM, thiaminepyrophosphate 0.27 mM, py- 
ruvate IO mM, GSH 2.5 mM, p-nitroaniline 0.15 mM, 
bovine serum albumin 1 mg/ml, and arylamine acetyl- 
transferase 75 pg protein/ml. 
The reaction was started by addition of 25 or 50 
pl of homogenate and run at 30” for 30 min. The 
reaction mixture was rapidly cooled to i-2’ and im- 
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mediately spun at 20,000 g for 10 min. The supernatant 
was decanted into a cuvette and the decrease in absorp- 
tion at 380 nm was measured against a blank reaction 
mixture which had been incubated in the absence of 
CoA-SH and thiaminepyrophosphate. All assays were 
run in triplicates. 
2.2. Preparation of arylamine acetyltransferase 
This enzyme was prepared from pigeon liver ac- 
cording to Tabor et al. [6] as described by Wieland 
[7] with the only variation that 20 mM phosphate in- 
stead of 10 mM phosphate was used for the elution of 
the enzyme from the Al(OH)s gel (C,). Arylamine 
acetyltransferase activity was measured in the com- 
bined assay with acetylphosphate and phosphotrans- 
acetylase as described by Tabor et al. [6]. The specific 
activity of the preparation used was 0.24 pmole 
p-nitroaniline acetylated/min/mg protein at 25’ 
corresponding to a specific activity of 795 in terms 
of Tabor’s [8] definition. 
2.3. Determination ofprotein and metabolites 
For determination of the protein concentration 
aliquots of the homogenates were first treated with 
desoxycholate (6% final concentration) and then 
measured by the biuret method. ATP [93 , ADP [lo] 
and AMP [lo] were determined enzymic optically. 
3. Results and discussion 
When pyruvate dehydrogenase activity was tested 
immediately after homogenization the activity was 
rather low (table 1). During the incubation in the 
presence of 15 mM Mg*+ the activity increased gradually 
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Fig. 1. Inhibition by ATP of the increase in pyruvate dehy- 
drogenase activity during incubation at 37’ in the presence 
of 15 mM Mg*‘. Liver tissue was obtained by freeze clamping 
and homogenized (for experimental details see text). Aliquots 
were used for determinations of pyruvate dehydrogenase acti- 
vity before and after various periods of incubation in the pres- 
ense of Mg*+. After 60 min of incubation ATP (5 mM final 
concentration) was added to an aliquot of the incubated ho- 
mogenate and the incubation with and without ATP was con- 
tinued for another 60 min. 
and reached a plateau after 90 to 120 min. When ATP 
(5 mM) was added after 60 min and the incubation 
was continued for another 60 mitt, pyruvate dehy- 
drogenase activity declined instead of increasing (fig. 1). 
When the homogenate was incubated in the ab- 
sence of exogenous Mg*’ there was likewise an in- 
crease in pyruvate dehydrogenase activity, but this in- 
crease was only about l/3 of that seen in presence of 
exogenous Mg”. 
Table 1 
Ac$;ity of pyruvate dehydrogenase in livers from saline or fructose treated rats before and after incubation in the presence of 
Mg (15 mM) for 120 min. The initial activity is also expressed as percentage of total activity of pyruvate dehydrogenase. The 
activities are expressed as pmoles p-nitroaniline acetylated/min/g wet liver. The values represent he means’? S.E.M. Each single 
experimental value was calculated as the mean value of triplicate determinations of enzyme activity. 
~~~~ 
Activity before incubation Activity after incubation Initial activity as percentage Number of 
Treatment _ of total activity experiments 
(pmole/min/g liver) (%) (n) 
Saline 0.0662+0.0071 1.070~.053 6.2OkO.67 11 
Fructose 0.1340M.0122* 1.020~.099 13.64+1.38* 12 
* Values differ significantly from the corresponding control value 0, <O.OOl). 
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Table 2 
Concentrations of ATP, AMP and ATP + ADP + AMP, and ATP/ADP ratios in livers from saline or fructose treated rats (for experi- 
mental details see text). The values were obtained 7 min after the beginning of an intravenous injection of saline or 1.8 mmole/kg 
of fructose. The values represent he means 2 S.E.M. 
Treatment 
ATP ADP AMP ATP + ADP + AMP 
ATP/ADP 
Number of 
experiments 
(IJmoles/g wet liver) (ratio) (n) 
Saline 
Fructose 
2.568 f0.032 0.77Oti.120 0.321f0.080 3.677 jro.216 3.543 kO.611 5 
1.050*?0.080 0.564~0.081 0.400+0.062 2.034*M.181 1.914***0.261 5 
*, ** Values differ significantly from the corresponding control values @ < 0.001 and p <0.025, resp.). 
The activity of pyruvate dehydrogenase immediate- 
ly after homogenization was significantly higher in 
livers from fructose injected rats compared with 
control rats (table 1). When the activity of pyruvate 
dehydrogenase immediately after homogenization 
was expressed as percentage of total pyruvate dehy- 
drogenase activity, again the percentage of active 
pyruvate dehydrogenase was significantly higher in 
livers from fructose treated rats (table 1). There was 
no significant difference in total pyruvate dehydrogen- 
ase activity between fructose treated and saline treated 
rats (table 1). The increase in active pyruvate dehy- 
drogenase in livers from fructose treated rats was 
accompanied by a dramatic decrease in the concentra- 
tion of ATP and of ATP + ADP + AMP and of the 
ATP/ADP ratio (table 2) which is in accordance with 
the findings of MPenpaa et al. [ 11, 121 and our 
previous results obtained in isolated perfused rat livers 
[II * 
The low percentage of active pyruvate dehydrogen- 
ase in normal rat livers corresponds well with similar 
results reported recently by Wieland [ 131 . Though 
Wieland [ 131 could not detect a change in the percent- 
age of active pyruvate dehydrogenase during starvation 
or diabetes, the present result demonstrates that an 
interconversion from inactive to active pyruvate 
dehydrogenase can take place also in liver under in 
vivo conditions. The rapid increase inthe percentage 
of active pyruvate dehydrogenase after fructose ex- 
plains well the rapid enhancement of pyruvate oxida- 
tion in the isolated perfused rat liver after the addi- 
tion of fructose to the medium [l] . 
It remains to be clarified by further experiments 
whether smaller metabolic perturbations than those 
following the application of fructose will also affect 
metabolic flux rates in liver by an effect on the inter- 
conversion reaction of pyruvate dehydrogenase. 
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